Total Body Irradiation for Marrow or Stem-Cell Transplantation

References

• Bortin M M, Horowitz M M, Rimm A A. Progress report from the international bone marrow transplant registry. Bone Marrow Transpl 1992; 10: 113–122
   PubMed Web of Science ®Google Scholar
• Appelbaum F R. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA 1996; 46: 142–164
   Google Scholar
• Vriesendorp H M. Radiobiological speculations on therapeutic total body irradiation. Crit Rev Oncol Hematol 1990; 10: 211–224
   PubMed Web of Science ®Google Scholar
• Vriesendorp H M. Prediction of effects of therapeutic total body irradiation in man. Radiother Oncol 1990, Suppl 1: 37–50
   PubMedGoogle Scholar
• Vriesendorp H M, Chu H, Ochran T G, et al. Radiobiology of total body radiation. Bone Marrow Transpl 1994; 14: 54–58, Suppl
   Google Scholar
• Vriesendorp H M, Chu H, Ochran T G, et al. Total body irradiation and the therapeutic ratio of bone marrow transplantation. Bone Marrow Transpl 1995; 15(Suppl 1)S193–S198
   PubMedGoogle Scholar
• Shank B. Radiotherapeutic principles of bone marrow transplantation. Bone Marrow Transplantation, S J Forman, K G Blume, E D Thomas. Blackwell Scientific Publishers, Boston 1994; 96–113
   Google Scholar
• Peters L J, Withers H R, Cundiff J H, Dicke K A. Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation. Radiology 1979; 131: 243–247
   PubMed Web of Science ®Google Scholar
• Lehnert S, Rybka W B, Suissa S, Giambattisto D. Radiation response of haematopoietic cell lines of human origin. Int J Radiat Biol 1986; 49: 423–431
   Web of Science ®Google Scholar
• Shank B. Hyperfractionation (T.I.D.) vs. single dose irradiation in human acute lymphocytic leukemia cells: Application to TBI for marrow transplantation. Radiother Oncol 1993; 27: 30–35
   PubMed Web of Science ®Google Scholar
• O'Donoghue J A, Wheldon T E, Gregor A. The implications of in vitro radiation-survival curves for the optimal scheduling of total-body irradiation with bone marrow rescue in the treatment of leukaemia. Br J Radiol 1987; 60: 279–283
   PubMed Web of Science ®Google Scholar
• O'Donoghue J A. Fractionated versus low dose-rate total body irradiation. Radiobiological considerations in the selection of regimes. Radiother Oncol 1986; 7: 241–247
   PubMed Web of Science ®Google Scholar
• Vitale V, Scarpati D, Frassoni F, Corvo R. Total body irradiation: Single dose, fractions, dose rate. Bone Marrow Transpl 1989; 4(Suppl l)233–235
   PubMedGoogle Scholar
• Ozsahin M, Pene F, Touboul E, et al. Total-body irradiation before bone marrow transplantation; results of two randomized instantaneous dose rates in 157 patients. Cancer 1992; 69: 2853–2865
   PubMed Web of Science ®Google Scholar
• Cosset J M, Baume D, Pico J L, et al. Single dose versus hyper-fractionated total body irradiation before allogeneic bone marrow transplantation: A non-randomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol 1989; 15: 151–160
   PubMed Web of Science ®Google Scholar
• Socie G, Devergie A, Girinsky T, et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int J Radiat Oncol Biol Phys 1991; 20: 397–404
   PubMed Web of Science ®Google Scholar
• Shank B, Chu F CH, Dinsmore R, et al. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys 1983; 9: 1607–1611
   PubMed Web of Science ®Google Scholar
• Kim T H, McGlave P B, Ramsay N, et al. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Oncol Biol Phys 1990; 19: 889–897
   PubMed Web of Science ®Google Scholar
• Pino Y, Torres J L, Bross D S, et al. Risk factors in interstitial pneumonitis following allogenic bone marrow transplantation. Int J Radiat Oncol Biol Phys 1982; 8: 1301–1307
   PubMed Web of Science ®Google Scholar
• Kim T H, Rybka W B, Lehnert S, et al. Interstitial pneumonitis following total body irradiation for bone marrow transplantation using two different dose rates. Int J Radiat Oncol Biol Phys 1985; 11: 1285–1291
   PubMed Web of Science ®Google Scholar
• Thomas E D, Clift R A, Hersman J, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys 1982; 8: 817–821
   PubMed Web of Science ®Google Scholar
• Blume K G, Forman S J, Snyder D S, et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation 1987; 43: 389–392
   PubMed Web of Science ®Google Scholar
• Devergie A, Reiffers J, Vernant J P, et al. Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: Factors associated with relapse. Bone Marrow Transpl 1990; 5: 379–386
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, van Lint M T, Frassoni F, et al. Late complications of allogeneic bone marrow transplantation. Med Oncol Tumor Pharmacother 1991; 8: 261–263
   PubMedGoogle Scholar
• Sutton L, Kuentz M, Cordonnier C, et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: Factors predictive of transplant-related mortality and influence of total body irradiation modalities. Bone Marrow Transpl 1993; 12: 583–589
   PubMed Web of Science ®Google Scholar
• Benyunes M C, Sullivan K M, Deeg H J, et al. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 661–670
   PubMed Web of Science ®Google Scholar
• Deeg H J, Sullivan K M, Buckner C D, et al. Marrow transplantation for acute non lymphoblastic leukemia in first remission: Toxicity and long-term follow-up of patients conditioned wiffi single dose or fractionated total body irradiation. Bone Marrow Transpl 1986; 1: 151–157
   PubMed Web of Science ®Google Scholar
• McDonald G B, Sharma P, Matthews D E, et al. Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116–122
   PubMed Web of Science ®Google Scholar
• Resbeut M, Cowen D, Blaise D, et al. Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: Is there a best choice. Int J Radiat Oncol Biol Phys 1995; 31: 509–517
   PubMed Web of Science ®Google Scholar
• Sanders J E. Long-term Follow-up Team: Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transpl 1991; 8(Suppl l)2–4
   PubMedGoogle Scholar
• Hovi L, Saarinen U M, Siimes M A. Growth failure in children after total body irradiation preparative for bone marrow transplantation. Bone Marrow Transpl 1991; 8(Suppl 1)10–13
   PubMedGoogle Scholar
• Clift R A, Buckner C D, Appelbaum F R, et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens. Blood 1991; 77: 1660–1665
   PubMed Web of Science ®Google Scholar
• Clift R, Buckner C D, Bianco J, et al. Marrow transplantation in patients with acute myeloid leukemia. Leukemia 1992; 6(Suppl 2)104–109
   PubMedGoogle Scholar
• Brochstein J A, Kernan N A, Groshen S, et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987; 317: 1618–1624
   PubMed Web of Science ®Google Scholar
• Labar B, Bogdanic V, Nemet D, et al. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. Bone Marrow Transpl 1992; 9: 343–347
   PubMed Web of Science ®Google Scholar
• Girinsky T, Socie G, Ammarguellat H, et al. Consequences of two different doses to the lungs during a single dose of total body irradiation: Results of a randomized study on 85 patients. Int J Radiat Oncol Biol Phys 1994; 30: 821–824
   PubMed Web of Science ®Google Scholar
• DeLaCamara R, Tomas J F, Figuera A, et al. High dose busulfan and seizures. Bone Marrow Transpl 1991; 7: 363–364
   PubMed Web of Science ®Google Scholar
• Morgan M, Dodds A, Atkinson K, et al. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 529–534
   PubMed Web of Science ®Google Scholar
• Wingard J R, Plotnick L P, Freemer C S, et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992; 79: 1068–1073
   PubMed Web of Science ®Google Scholar
• Dusenbery K E, Daniels K A, McClure J S, et al. Randomized comparison of cyclophosphamide-total body irradiation vs. busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys 1995; 31: 119–128
   PubMed Web of Science ®Google Scholar
• Dusenbery K E, Steinbuch M, McGlave P B, et al. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience. Int J Radiat Oncol Biol Phys 1996; 36: 335–343
   PubMed Web of Science ®Google Scholar
• Schwerdtfeger R, Kirsch A, Sonntag S, Sauberlich S, Siegert W. Allogeneic bone marrow transplantation in chronic myeloid leukemia–what is the best conditioning regime. Bone Marrow Transpl 1993; 12(Suppl 2)13
   Google Scholar
• Miller G, Wagner J E, Vogelsang G B, Santos G W. A randomized trial of busulfan-cyclophosphamide (Bu-Cy) versus cyclophosphamide-total body irradiation (Cy-TBI) as preparative regimen for patients with chronic myelogenous leukemia (CML). Blood 1991; 78(Suppl. l)291a, (abstract)
   Google Scholar
• Devergie A, Blaise D, Attal M, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: A randomized trial of busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: A report from the French Society of Bone Marrow Graft (SFGM). Blood 1995; 85: 2263–2268
   PubMed Web of Science ®Google Scholar
• Clift R A, Buckner C D, Thomas E D, et al. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036–2043
   PubMed Web of Science ®Google Scholar
• Blume K G, Kopecky K J, Henslee-Downey J P, et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission. Blood 1993; 81: 2187–2193
   PubMed Web of Science ®Google Scholar
• Ringden O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplant Group. Blood 1994; 83: 2723–2730
   PubMed Web of Science ®Google Scholar
• Inoue T, Ikeda H, Yamazaki H, et al. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission. Strahlenther Onkol 1993; 169: 250–255
   PubMedGoogle Scholar
• Labopin M, Ringden O, Mandelli F, et al. Busulfan vs total body irradiation combined with cyclophosphamide as conditioning for autologous or allogeneic bone marrow transplantation in patients with acute leukemia. Blood 1995; 86: 94a, (abstract)
   Google Scholar
• Gratwohl A, Hermans J, Biezen A V, et al. No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transpl 1992; 10: 147–152
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Hermans J, Biezen A V, et al. Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transpl 1996; 17(Suppl 1)S61, (abstract)
   Google Scholar
• Fruchtman S, Scigliano E, Isola L, et al. Hyperfractionated total body irradiation (HF-TBI) and whole allogeneic marrow grafts: An intensive, safe, and highly efficacious approach to the cure of leukemia. Blood 1995; 86(Suppl l)945a, (abstract)
   Google Scholar
• Pezner R D, Nademanee A, Niland J C, Vora N, Forman S J. Involved field radiation therapy for Hodgkin's disease autologous bone marrow transplantation regimens. Radiother Oncol 1995; 34: 23–29
   PubMed Web of Science ®Google Scholar
• Mundt A J, Sibley G, Williams S, et al. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys 1995; 33: 261–270
   PubMed Web of Science ®Google Scholar
• Rapoport A P, Rowe J M, Kouides P A, et al. One hundred auto-transplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome. J Clin Oncol 1993; 11: 2351–2361
   PubMed Web of Science ®Google Scholar
• Poen J P, Hoppe R T, Horning S J. High-dose therapy and autolo-Shank gous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival. Int J Radiat Oncol Biol Phys 1996; 36: 3–12
   PubMed Web of Science ®Google Scholar
• Phillips G L, Fay J W, Herzig R H, et al. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradio-therapy and autologous marrow transplantation. Blood 1990; 75: 831–838
   PubMed Web of Science ®Google Scholar
• Matthews D C, Appelbaum F R, Eary J F, et al. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 1995; 85: 1122–1131
   PubMed Web of Science ®Google Scholar
• Blaise D, Maraninchi D, Archimbaud E, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Groupe d'Etudes de la Greffe de Moelle Osseuse. Blood 1993; 79: 2578–2582
   Web of Science ®Google Scholar